How have NIPT shares performed in 2024?

Premaitha Health's stock was trading at GBX 9.10 on January 1st, 2024. Since then, NIPT shares have increased by 0.0% and is now trading at GBX 9.10. View the best growth stocks for 2024 here .

How were Premaitha Health's earnings last quarter?

Premaitha Health PLC (LON:NIPT) released its quarterly earnings data on Friday, December, 29th. The company reported ($2.00) earnings per share for the quarter. The business earned $2.71 million during the quarter.

What other stocks do shareholders of Premaitha Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Premaitha Health investors own include IQE (IQE) , Avanti Communications Group (AVN) , Chesapeake Utilities (CPK) , Plethora Solutions (PLE) , Vedanta Resources (VED) , Mitie Group (MTO) , Scancell (SCLP) , Sirius Minerals (SXX) , Advanced Micro Devices (AMD) and Aviva (AV) .

How do I buy shares of Premaitha Health?

Shares of NIPT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:NIPT

Premaitha Health (NIPT) Share Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free NIPT Stock Alerts

GBX 9.10

+0.20 (+2.25%)

(As of 11/6/2018)

Compare

Today's Range: 9.10
▼
9.10
50-Day Range: 9.10
▼
9.10
52-Week Range: 3.78
▼
14.80

Volume: 1.57 million shs
Average Volume: 1.35 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Premaitha Health alerts:

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Premaitha Health Stock (LON:NIPT)

Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.

NIPT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

NIPT Stock News Headlines

April 13, 2024 | americanbankingnews.com

Premaitha Health (LON:NIPT) Shares Pass Above 50-Day Moving Average of $9.10

June 14, 2023 | forbes.com

Weight Loss Diets And Workouts For Women To Try In 2023

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

May 10, 2023 | marketwatch.com

Europe Non Invasive Prenatal Testing Market Scope, Trends, Growth Status, Share, Revenue and Forecast 2023 to 2031

May 10, 2023 | marketwatch.com

Non-Invasive Prenatal Testing Market Key Players, Revenue, Share, Future Trends, Growth and Forecast 2023 to 2031

May 5, 2023 | marketwatch.com

Non Invasive Prenatal Testing (NIPT) Market Size (2023 to 2030) New Study on Global Industry Trends and Forecast with Top Countries Data

March 18, 2023 | finance.yahoo.com

Non-Invasive Prenatal Testing (NIPT) Market Growth (2022-2030) | Industry Share, Size, Trends and Global Forecast Report

March 9, 2023 | fool.co.uk

Premaitha Health

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

February 23, 2023 | uk.finance.yahoo.com

Non-invasive Prenatal Testing Global Market Report 2023

February 19, 2023 | marketwatch.com

Non-Invasive Prenatal Testing (NIPT) Market 2023: A Status of Top Regions and Companies with Growth Prospects

July 12, 2022 | marketwatch.com

India Non-Invasive Prenatal Testing (NIPT) Market Size to reach 62 Million USD by 2022-2028

March 6, 2022 | fool.co.uk

Persimmon (LSE:PSN)

November 10, 2021 | lse.co.uk

Premaitha Health Share Chat

See More Headlines

Receive NIPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premaitha Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 12/29/2017
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Medical Laboratories & Research
Sub-Industry: N/A
Current Symbol: LON:NIPT
Previous Symbol: LON:VIY
CUSIP: N/A
CIK: N/A
Web: www.premaitha.com
Phone: +44-161-6676865
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Dr. Stephen Little (Age 61)
Exec. Vice Chairman
Mr. Barry Hextall
CFO, Sec. & Exec. Director
Mr. Peter Collins (Age 59)
Chief Bus. Officer & Exec. Director
Mr. Lyn Fafydd Rees (Age 45)
CEO & Director
Dr. Chia-Han Chan (Age 42)
Chief Scientific Officer & Director

Key Competitors

View All Competitors

NIPT Stock Analysis - Frequently Asked Questions

How have NIPT shares performed in 2024?: Premaitha Health's stock was trading at GBX 9.10 on January 1st, 2024. Since then, NIPT shares have increased by 0.0% and is now trading at GBX 9.10.
View the best growth stocks for 2024 here.
How were Premaitha Health's earnings last quarter?: Premaitha Health PLC (LON:NIPT) released its quarterly earnings data on Friday, December, 29th. The company reported ($2.00) earnings per share for the quarter. The business earned $2.71 million during the quarter.
What other stocks do shareholders of Premaitha Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Premaitha Health investors own include IQE (IQE), Avanti Communications Group (AVN), Chesapeake Utilities (CPK), Plethora Solutions (PLE), Vedanta Resources (VED), Mitie Group (MTO), Scancell (SCLP), Sirius Minerals (SXX), Advanced Micro Devices (AMD) and Aviva (AV).
How do I buy shares of Premaitha Health?: Shares of NIPT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:NIPT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial